CLINICAL_TRIALS
trial_result
· 2012-08-13
Clinical Trial Update: A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma [Phase 2]
Summary
A Phase 2 clinical trial of romidepsin for progressive or relapsed peripheral T-cell lymphoma has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-13